Hub : Traits :

Coronary Artery Disease (CAD)

57 significantly associated models · 23 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 109098737 110517617 3 1 7.0e-10 2.9e-10 1.0e+00 100 PSRC1
2 2 202952678 204788156 7 1 3.9e-11 1.8e-11 1.0e+00 100 ICA1L
3 3 137189600 138819532 2 1 4.1e-08 3.3e-08 2.4e-01 96 MRAS
4 6 12020241 13990267 2 1 2.4e-13 2.5e-11 9.5e-01 100 RP1-257A7.5
5 8 19547307 20071503 1 1 8.4e-08 3.0e-07 9.2e-02 89 LPL
6 9 21303958 22819407 2 1 5.8e-21 2.3e-30 3.5e-11 67 CDKN2B
7 9 135883620 136399075 1 1 8.2e-08 1.2e-07 1.7e-02 80 ABO
8 12 111882485 112443960 1 1 1.4e-07 1.4e-07 1.0e+00 100 ACAD10
9 15 78360691 79802863 2 2 9.6e-11 2.9e-09 4.7e-03 77 ADAMTS7 MORF4L1
10 17 46258510 47685050 1 1 2.9e-07 3.6e-06 2.4e-02 76 RP11-463M16.4
11 19 10793749 12191233 1 1 4.2e-08 9.7e-10 1.0e+00 100 EPOR

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Depressed Affect (Nagel 2018) 1.61 1 0 0.0 0.00 1.0e+00 ICA1L
Alzheimer’s Disease (in father) 1.42 1 0 0.0 0.00 1.0e+00 ICA1L
Alzheimer’s Disease (including proxy) 1.59 1 0 0.0 0.00 1.0e+00 ICA1L
Irritable Bowel Disease (IBD) 0.89 1 0 0.0 0.00 1.0e+00 ACAD10
Reaction Time 2.46 1 1 2.2 0.00 1.0e+00 ACAD10
Breast Cancer 1.37 1 0 0.0 0.00 1.0e+00 CDKN2B
Ovarian Cancer 3.14 1 0 0.0 0.00 1.0e+00 ABO
HDL Cholesterol 24.98 2 2 4.4 0.00 1.0e+00 LPL PSRC1
LDL Cholesterol 54.97 4 3 6.7 0.65 3.5e-01 ABO ACAD10 EPOR PSRC1
Primary Biliary Cirrhosis 2.69 2 0 0.0 0.00 1.0e+00 ACAD10 EPOR
Triglycerides 25.44 1 1 2.2 0.00 1.0e+00 LPL
Type 2 Diabetes (T2D) (2012) 3.84 1 0 0.0 0.00 1.0e+00 CDKN2B
Blood Eosinophil Count 8.49 5 2 4.4 -0.07 9.1e-01 ABO ACAD10 EPOR ICA1L LPL
Blood Platelet Count 1.73 7 3 6.7 0.36 4.3e-01 ACAD10 ADAMTS7 CDKN2B ICA1L LPL MORF4L1 RP11-463M16.4
Blood Red Count 3.22 3 2 4.4 0.00 1.0e+00 ABO ACAD10 RP1-257A7.5
Blood White Count 6.45 5 2 4.4 0.02 9.8e-01 ABO ACAD10 CDKN2B EPOR RP1-257A7.5
Heel T-Score 1.37 2 1 2.2 0.00 1.0e+00 ABO PSRC1
BMI 1.66 5 1 2.2 -0.19 7.6e-01 ICA1L LPL MRAS RP11-463M16.4 RP1-257A7.5
Height 1.43 8 4 8.9 -0.72 4.4e-02 ABO ACAD10 EPOR ICA1L LPL MRAS PSRC1 RP11-463M16.4
Waist Hip Ratio (WHR) 2.13 3 1 2.2 0.00 1.0e+00 ADAMTS7 LPL MRAS
Systolic Blood Pressure 4.78 8 4 8.9 0.48 2.3e-01 ABO ACAD10 EPOR ICA1L MORF4L1 MRAS RP11-463M16.4 RP1-257A7.5
Smoking Status 2.82 2 0 0.0 0.00 1.0e+00 ICA1L RP11-463M16.4
Allergy or Eczema 1.68 2 1 2.2 0.00 1.0e+00 ABO ACAD10
Cardiovascular Disease 8.48 6 6 13.3 0.98 5.8e-04 ACAD10 EPOR LPL MRAS PSRC1 RP11-463M16.4
Hypothyroidism (self reported) 5.95 1 1 2.2 0.00 1.0e+00 ACAD10
Respiratory disease 2.13 1 1 2.2 0.00 1.0e+00 ICA1L
Type 2 Diabetes (T2D) (2018) 3.43 3 0 0.0 0.00 1.0e+00 LPL MRAS RP11-463M16.4
Lung FEV1/FVC ratio 1.58 4 1 2.2 -0.45 5.5e-01 ABO ACAD10 ICA1L PSRC1
Lung FVC 1.08 2 0 0.0 0.00 1.0e+00 ABO ICA1L
Chronotype (morning person) 1.15 1 0 0.0 0.00 1.0e+00 ACAD10
Hair Pigment 0.45 6 1 2.2 -0.23 6.6e-01 ACAD10 ADAMTS7 CDKN2B EPOR MRAS RP11-463M16.4
Tanning 0.31 1 0 0.0 0.00 1.0e+00 EPOR
Hand grip strength (left) 1.53 2 0 0.0 0.00 1.0e+00 ABO RP1-257A7.5
Number of treatments/medications taken 4.29 2 0 0.0 0.00 1.0e+00 LPL PSRC1
Average weekly spirits intake 1.71 1 0 0.0 0.00 1.0e+00 ICA1L
Systolic blood pressure, automated reading 3.30 5 2 4.4 0.43 4.6e-01 ACAD10 EPOR MRAS RP11-463M16.4 RP1-257A7.5
Angina 19.92 7 4 8.9 0.99 3.3e-05 ADAMTS7 CDKN2B LPL MORF4L1 PSRC1 RP11-463M16.4 RP1-257A7.5
Medication for hormone replacement therapy 1.37 1 0 0.0 0.00 1.0e+00 ICA1L
Medication: Metformin 3.64 3 0 0.0 0.00 1.0e+00 ABO CDKN2B LPL
Pack years adult smoking proportion 5.71 2 2 4.4 0.00 1.0e+00 ADAMTS7 MORF4L1
Impedance of leg (right) 1.13 1 1 2.2 0.00 1.0e+00 RP11-463M16.4
Leg fat-free mass (left) 1.31 4 0 0.0 -0.97 2.7e-02 ACAD10 EPOR MRAS PSRC1
Trunk fat percentage 1.89 3 1 2.2 0.00 1.0e+00 ABO MRAS RP1-257A7.5
Hand grip strength (right) 1.80 2 0 0.0 0.00 1.0e+00 ABO RP1-257A7.5
Townsend deprivation index at recruitment 1.77 1 0 0.0 0.00 1.0e+00 ICA1L
Current tobacco smoking 2.75 1 1 2.2 0.00 1.0e+00 ICA1L
Taking other prescription medications 2.57 2 0 0.0 0.00 1.0e+00 ACAD10 MRAS
Heel bone mineral density (BMD) T-score, automated (left) 1.28 1 0 0.0 0.00 1.0e+00 ABO
High blood pressure 5.00 5 4 8.9 0.16 8.0e-01 ABO ACAD10 MRAS RP11-463M16.4 RP1-257A7.5
Hayfever, allergic rhinitis or eczema 1.41 1 0 0.0 0.00 1.0e+00 ABO
Multivitamins +/- minerals 2.19 1 0 0.0 0.00 1.0e+00 MORF4L1
Diverticular disease/diverticulitis (self-reported) 3.12 2 0 0.0 0.00 1.0e+00 ACAD10 ICA1L
Medication: Atenolol 5.47 1 0 0.0 0.00 1.0e+00 ACAD10
Medication: Levothyroxine sodium 4.79 1 1 2.2 0.00 1.0e+00 ACAD10
Sitting height 1.20 3 1 2.2 0.00 1.0e+00 ICA1L MORF4L1 RP11-463M16.4
Chronic bronchitis/emphysema (father) 2.87 1 0 0.0 0.00 1.0e+00 ADAMTS7
High blood pressure (mother) 3.43 3 0 0.0 0.00 1.0e+00 MRAS RP11-463M16.4 RP1-257A7.5
Body mass index (BMI) 1.54 2 0 0.0 0.00 1.0e+00 RP11-463M16.4 RP1-257A7.5
Impedance of leg (left) 1.32 2 1 2.2 0.00 1.0e+00 LPL RP11-463M16.4
Leg predicted mass (left) 1.32 4 0 0.0 -0.98 2.4e-02 ACAD10 EPOR MRAS PSRC1
Trunk fat mass 1.57 4 0 0.0 -0.58 4.2e-01 ABO ACAD10 MRAS RP1-257A7.5
Waist circumference 1.35 3 0 0.0 0.00 1.0e+00 ACAD10 ICA1L RP1-257A7.5
Number of incorrect matches in round 1.15 1 0 0.0 0.00 1.0e+00 MRAS
Past tobacco smoking 2.84 2 0 0.0 0.00 1.0e+00 ACAD10 RP11-463M16.4
Had menopause 2.25 1 0 0.0 0.00 1.0e+00 LPL
Forced vital capacity (FVC) 1.41 3 0 0.0 0.00 1.0e+00 ABO EPOR ICA1L
Heel bone mineral density (BMD) T-score, automated (right) 1.43 1 0 0.0 0.00 1.0e+00 ABO
Heart attack 17.02 6 3 6.7 0.99 5.3e-05 CDKN2B ICA1L LPL MRAS PSRC1 RP1-257A7.5
Allergy 3.31 1 1 2.2 0.00 1.0e+00 ABO
Medication: Ramipril 3.00 1 0 0.0 0.00 1.0e+00 MRAS
Medication: Simvastatin 17.04 6 3 6.7 0.93 7.0e-03 ABO CDKN2B EPOR LPL MRAS PSRC1
Illnesses of siblings 2.76 1 0 0.0 0.00 1.0e+00 RP11-463M16.4
Weight 1.43 4 0 0.0 -0.96 3.6e-02 ACAD10 EPOR MRAS RP1-257A7.5
Impedance of arm (right) 2.66 3 1 2.2 0.00 1.0e+00 ABO CDKN2B RP11-463M16.4
Arm fat percentage (right) 2.54 3 1 2.2 0.00 1.0e+00 ABO ICA1L RP1-257A7.5
Trunk fat-free mass 1.95 4 4 8.9 -0.99 7.8e-03 ABO ACAD10 EPOR PSRC1
Hip circumference 1.65 3 0 0.0 0.00 1.0e+00 ACAD10 ADAMTS7 MRAS
Father's age at death 6.33 4 0 0.0 -0.97 3.1e-02 ABO CDKN2B LPL PSRC1
Frequency of tiredness / lethargy in last 2 weeks 1.59 1 0 0.0 0.00 1.0e+00 ACAD10
Falls in the last year 1.46 1 0 0.0 0.00 1.0e+00 ICA1L
Forced expiratory volume in 1-second (FEV1) 1.67 2 0 0.0 0.00 1.0e+00 ABO EPOR
Asthma 1.52 1 0 0.0 0.00 1.0e+00 ICA1L
Medication: Ibuprofen (e.g. Nurofen) 4.12 1 1 2.2 0.00 1.0e+00 RP1-257A7.5
Medication: Cholesterol lowering 21.71 5 3 6.7 0.92 2.7e-02 ABO CDKN2B EPOR LPL PSRC1
Lung cancer (father) 4.26 2 0 0.0 0.00 1.0e+00 ADAMTS7 MORF4L1
Illnesses of mother 3.12 1 0 0.0 0.00 1.0e+00 CDKN2B
Forced expiratory volume in 1-second (FEV1), Best measure 1.93 2 0 0.0 0.00 1.0e+00 ABO EPOR
Pulse wave Arterial Stiffness index 2.76 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Impedance of arm (left) 2.79 3 1 2.2 0.00 1.0e+00 ABO ACAD10 RP11-463M16.4
Arm fat mass (right) 1.81 4 0 0.0 -0.60 4.0e-01 ABO ACAD10 MRAS RP1-257A7.5
Trunk predicted mass 1.95 4 4 8.9 -0.99 7.9e-03 ABO ACAD10 EPOR PSRC1
Standing height 1.40 5 2 4.4 -0.62 2.7e-01 ACAD10 EPOR ICA1L PSRC1 RP11-463M16.4
Birth weight of first child 2.01 2 0 0.0 0.00 1.0e+00 ACAD10 EPOR
Peak expiratory flow (PEF) 1.81 2 1 2.2 0.00 1.0e+00 ABO EPOR
Pulse wave reflection index 2.50 1 0 0.0 0.00 1.0e+00 ICA1L
Blood clot in the leg (DVT) 20.92 1 1 2.2 0.00 1.0e+00 ABO
Medication: Paracetamol 3.22 2 1 2.2 0.00 1.0e+00 ICA1L RP1-257A7.5
Headache pain in last month 5.09 3 1 2.2 0.00 1.0e+00 ACAD10 ICA1L RP1-257A7.5
Medication for cholesterol, blood pressure or diabetes 7.85 4 2 4.4 -0.94 5.7e-02 EPOR LPL PSRC1 RP11-463M16.4
Glaucoma (self-reported) 4.23 1 1 2.2 0.00 1.0e+00 CDKN2B
Hypothyroidism/myxoedema (self-reported) 4.76 1 1 2.2 0.00 1.0e+00 ACAD10
Birth weight 1.47 1 0 0.0 0.00 1.0e+00 ACAD10
Chronic bronchitis/emphysema (mother) 2.78 1 0 0.0 0.00 1.0e+00 MORF4L1
Forced vital capacity (FVC), Best measure 1.70 2 0 0.0 0.00 1.0e+00 EPOR ICA1L
Body fat percentage 1.83 4 0 0.0 -0.59 4.1e-01 ABO ICA1L MRAS RP1-257A7.5
Leg fat percentage (right) 1.46 2 0 0.0 0.00 1.0e+00 ICA1L RP1-257A7.5
Arm fat-free mass (right) 2.13 4 2 4.4 -0.99 1.0e-02 ABO ACAD10 EPOR PSRC1
Comparative body size at age 10 0.89 1 0 0.0 0.00 1.0e+00 RP11-463M16.4
Wheeze or whistling in the chest in last year 1.91 1 0 0.0 0.00 1.0e+00 ICA1L
Pulse wave peak to peak time 2.73 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Qualifications: College or University degree 1.27 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Medication for pain relief, constipation, heartburn 2.80 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Medication: Blood pressure 3.62 1 1 2.2 0.00 1.0e+00 RP11-463M16.4
Angina (self-reported) 20.41 7 5 11.1 0.99 4.5e-05 ADAMTS7 CDKN2B LPL MORF4L1 PSRC1 RP11-463M16.4 RP1-257A7.5
Migraine (self-reported) 5.31 2 1 2.2 0.00 1.0e+00 ICA1L RP1-257A7.5
Medication: Ibuprofen 3.77 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Mean time to correctly identify matches 2.62 1 1 2.2 0.00 1.0e+00 ACAD10
Heart disease (mother) 10.72 6 1 2.2 0.99 6.1e-05 ABO ACAD10 ADAMTS7 CDKN2B MORF4L1 RP1-257A7.5
Whole body fat mass 1.60 3 0 0.0 0.00 1.0e+00 ACAD10 MRAS RP1-257A7.5
Leg fat mass (right) 1.47 3 0 0.0 0.00 1.0e+00 ACAD10 MRAS RP1-257A7.5
Arm predicted mass (right) 2.10 5 2 4.4 -0.98 3.7e-03 ABO ACAD10 EPOR MRAS PSRC1
Pulse rate, automated reading 1.78 2 0 0.0 0.00 1.0e+00 ABO RP1-257A7.5
Alcohol intake frequency. 1.91 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Comparative height size at age 10 1.20 2 1 2.2 0.00 1.0e+00 ACAD10 PSRC1
Overall health rating 1.81 1 0 0.0 0.00 1.0e+00 RP11-463M16.4
Chest pain or discomfort 2.37 2 0 0.0 0.00 1.0e+00 CDKN2B LPL
Medication: Aspirin 11.23 7 2 4.4 0.99 1.8e-05 ABO CDKN2B EPOR LPL MRAS PSRC1 RP11-463M16.4
Knee pain experienced in last month 2.51 2 0 0.0 0.00 1.0e+00 ICA1L RP1-257A7.5
Hypertension (Self-reported) 4.66 5 3 6.7 0.16 8.0e-01 ABO ACAD10 MRAS RP11-463M16.4 RP1-257A7.5
Illnesses of father: Heart disease 19.55 10 5 11.1 0.99 6.9e-08 ABO ADAMTS7 CDKN2B EPOR ICA1L LPL MORF4L1 MRAS PSRC1 RP1-257A7.5
Smoking status: Previous 2.69 1 1 2.2 0.00 1.0e+00 ACAD10
Forced expiratory volume in 1-second (FEV1), predicted 1.51 1 0 0.0 0.00 1.0e+00 EPOR
Whole body fat-free mass 1.62 4 2 4.4 -0.99 1.3e-02 ABO ACAD10 EPOR PSRC1
Leg fat-free mass (right) 1.19 3 0 0.0 0.00 1.0e+00 ACAD10 EPOR PSRC1
Arm fat percentage (left) 2.45 4 1 2.2 -0.46 5.4e-01 ABO ICA1L MRAS RP1-257A7.5
Long-standing illness, disability or infirmity 2.95 2 0 0.0 0.00 1.0e+00 CDKN2B MRAS
Ever had bowel cancer screening 1.38 1 0 0.0 0.00 1.0e+00 ABO
Diabetes diagnosed by doctor 2.82 1 0 0.0 0.00 1.0e+00 MRAS
Medication for cholesterol 5.40 3 0 0.0 0.00 1.0e+00 ACAD10 MRAS PSRC1
Breast cancer (self-reported) 3.37 1 0 0.0 0.00 1.0e+00 CDKN2B
Asthma (self-reported) 1.40 1 0 0.0 0.00 1.0e+00 ICA1L
Medication: Aspirin 11.32 6 2 4.4 0.99 1.3e-04 CDKN2B EPOR LPL MRAS PSRC1 RP11-463M16.4
Illnesses of father: None of the above (group 1) 5.39 1 1 2.2 0.00 1.0e+00 CDKN2B
Smoking status: Current 2.69 1 0 0.0 0.00 1.0e+00 ICA1L
Forced expiratory volume in 1-second (FEV1), predicted percentage 2.74 3 0 0.0 0.00 1.0e+00 ABO ADAMTS7 MORF4L1
Whole body water mass 1.59 4 1 2.2 -0.98 1.6e-02 ABO ACAD10 EPOR PSRC1
Leg predicted mass (right) 1.19 3 0 0.0 0.00 1.0e+00 ACAD10 EPOR PSRC1
Arm fat mass (left) 1.76 3 0 0.0 0.00 1.0e+00 ABO MRAS RP1-257A7.5
Number of self-reported non-cancer illnesses 3.95 3 0 0.0 0.00 1.0e+00 ACAD10 ICA1L PSRC1
Miserableness 1.34 1 0 0.0 0.00 1.0e+00 ICA1L
Guilty feelings 1.65 1 0 0.0 0.00 1.0e+00 ICA1L
Mother's age at death 2.18 1 0 0.0 0.00 1.0e+00 ABO
Eye problems/disorders: Glaucoma 6.25 1 1 2.2 0.00 1.0e+00 CDKN2B
Medication: Blood pressure 4.06 4 0 0.0 0.40 6.0e-01 ABO ACAD10 ADAMTS7 MRAS
High cholesterol (Self-reported) 28.62 5 4 8.9 0.79 1.1e-01 ABO EPOR ICA1L LPL PSRC1
Medication: Bendroflumethiazide 4.20 2 0 0.0 0.00 1.0e+00 ADAMTS7 RP11-463M16.4
Medication: Paracetamol 2.06 1 0 0.0 0.00 1.0e+00 RP1-257A7.5
Medication: Atorvastatin 16.46 5 3 6.7 0.94 1.6e-02 ABO CDKN2B EPOR LPL PSRC1
Ever smoked 2.45 1 0 0.0 0.00 1.0e+00 ACAD10
Basal metabolic rate 1.53 3 1 2.2 0.00 1.0e+00 ACAD10 EPOR PSRC1
Leg fat percentage (left) 1.38 2 0 0.0 0.00 1.0e+00 ICA1L RP1-257A7.5
Arm fat-free mass (left) 2.06 4 2 4.4 -0.97 2.7e-02 ABO ACAD10 EPOR PSRC1
Number of operations (self-reported) 1.53 1 0 0.0 0.00 1.0e+00 ABO
Diastolic blood pressure, automated reading 6.14 8 3 6.7 -0.15 7.1e-01 ABO ACAD10 ADAMTS7 CDKN2B ICA1L MORF4L1 MRAS RP11-463M16.4
Vascular/heart problems diagnosed by doctor 5.09 4 3 6.7 -0.59 4.1e-01 ABO ACAD10 MRAS RP11-463M16.4
Cholesterol lowering medication 18.67 7 4 8.9 0.84 1.9e-02 ABO CDKN2B EPOR ICA1L LPL MRAS PSRC1
Pain experienced in last month 2.27 2 0 0.0 0.00 1.0e+00 ACAD10 RP1-257A7.5
Basal cell carcinoma (self-reported) 2.49 1 0 0.0 0.00 1.0e+00 CDKN2B
Heart attack/myocardial infarction (self-reported) 17.52 7 3 6.7 0.99 5.1e-05 ACAD10 CDKN2B ICA1L LPL MRAS PSRC1 RP1-257A7.5
Deep venous thrombosis (DVT) (self-reported) 20.81 1 1 2.2 0.00 1.0e+00 ABO
Heart disease (siblings) 6.47 3 0 0.0 0.00 1.0e+00 ADAMTS7 PSRC1 RP1-257A7.5
Pack years of smoking 5.08 2 2 4.4 0.00 1.0e+00 ADAMTS7 MORF4L1
Impedance of whole body 1.60 3 1 2.2 0.00 1.0e+00 ABO PSRC1 RP11-463M16.4
Leg fat mass (left) 1.41 3 0 0.0 0.00 1.0e+00 ACAD10 MRAS RP1-257A7.5
Arm predicted mass (left) 2.16 4 2 4.4 -0.98 2.1e-02 ABO ACAD10 EPOR PSRC1

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 3 0.097 1.4
GTEx Adipose Visceral Omentum 1 0.055 1.5
GTEx Adrenal Gland 0 0.000 1.4
GTEx Artery Aorta 4 0.151 1.5
GTEx Artery Coronary 3 0.280 1.5
GTEx Artery Tibial 4 0.119 1.4
GTEx Brain Caudate basal ganglia 0 0.000 1.4
GTEx Brain Cerebellar Hemisphere 0 0.000 1.3
GTEx Brain Cerebellum 0 0.000 1.3
GTEx Brain Cortex 0 0.000 1.4
GTEx Brain Frontal Cortex BA9 1 0.120 1.5
GTEx Brain Hippocampus 0 0.000 1.2
GTEx Brain Hypothalamus 0 0.000 1.3
GTEx Brain Nucleus accumbens basal ganglia 0 0.000 1.2
GTEx Brain Putamen basal ganglia 0 0.000 1.5
GTEx Breast Mammary Tissue 0 0.000 1.4
GTEx Breast Mammary Tissue (Male) 0 0.000 1.4
GTEx Breast Mammary Tissue (Female) 0 0.000 1.4
GTEx Cells EBV-transformed lymphocytes 1 0.078 1.4
GTEx Cells Transformed fibroblasts 3 0.079 1.4
GTEx Colon Sigmoid 0 0.000 1.4
GTEx Colon Transverse 0 0.000 1.4
GTEx Esophagus Gastroesophageal Junction 0 0.000 1.4
GTEx Esophagus Mucosa 1 0.034 1.4
GTEx Esophagus Muscularis 0 0.000 1.4
GTEx Heart Atrial Appendage 0 0.000 1.4
GTEx Heart Left Ventricle 0 0.000 1.3
GTEx Liver 1 0.153 1.5
GTEx Lung 0 0.000 1.4
GTEx Muscle Skeletal 2 0.077 1.4
GTEx Nerve Tibial 2 0.052 1.4
GTEx Ovary 0 0.000 1.4
GTEx Pancreas 0 0.000 1.4
GTEx Pituitary 0 0.000 1.3
GTEx Prostate 0 0.000 1.4
GTEx Skin Not Sun Exposed Suprapubic 2 0.090 1.4
GTEx Skin Sun Exposed Lower leg 1 0.031 1.4
GTEx Small Intestine Terminal Ileum 0 0.000 1.3
GTEx Spleen 0 0.000 1.4
GTEx Stomach 0 0.000 1.4
GTEx Testis 1 0.035 1.4
GTEx Thyroid 1 0.028 1.4
GTEx Uterus 0 0.000 1.3
GTEx Vagina 0 0.000 1.3
GTEx Whole Blood 1 0.057 1.5
METSIM Adipose 2 0.048 1.3
NTR Blood 1 0.044 1.3
ROSMAP Brain Pre-frontal Cortex 2 0.050 1.3
YFS Blood 0 0.000 1.3
CommonMind Brain Pre-frontal Cortex 4 0.081 1.3
The Cancer Genome Atlas Bladder Urothelial Carcinoma 1 0.072 1.3
The Cancer Genome Atlas Breast Invasive Carcinoma 1 0.027 1.3
The Cancer Genome Atlas Cervical Squamous Cell Carcinoma 1 0.105 1.4
The Cancer Genome Atlas Colon Adenocarcinoma 3 0.173 1.4
The Cancer Genome Atlas Esophageal Carcinoma 0 0.000 1.3
The Cancer Genome Atlas Glioblastoma Multiforme 0 0.000 1.4
The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma 0 0.000 1.3
The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma 2 0.057 1.3
The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma 1 0.058 1.3
The Cancer Genome Atlas Brain Lower Grade Glioma 1 0.027 1.3
The Cancer Genome Atlas Liver Hepatocellular Carcinoma 1 0.104 1.4
The Cancer Genome Atlas Lung Adenocarcinoma 1 0.040 1.3
The Cancer Genome Atlas Lung Squamous Cell Carcinoma 1 0.047 1.3
The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma 0 0.000 1.4
The Cancer Genome Atlas Pancreatic Adenocarcinoma 0 0.000 1.3
The Cancer Genome Atlas Pheochromocytoma and Paraganglioma 0 0.000 1.4
The Cancer Genome Atlas Prostate Adenocarcinoma 0 0.000 1.3
The Cancer Genome Atlas Rectum Adenocarcinoma 1 0.167 1.4
The Cancer Genome Atlas Soft Tissue Sarcoma 0 0.000 1.4
The Cancer Genome Atlas Skin Cutaneous Melanoma 0 0.000 1.3
The Cancer Genome Atlas Stomach Adenocarcinoma 1 0.069 1.5
The Cancer Genome Atlas Testicular Germ Cell Tumors 0 0.000 1.2
The Cancer Genome Atlas Thyroid Carcinoma 1 0.023 1.3
The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma 0 0.000 1.4